NCT05885035View on ClinicalTrials.gov

Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 26, 2023

Study Completion Date

June 26, 2023

Conditions
Cellulite
Interventions
DRUG

Calcium Hydroxyapatite

Each syringe of CaHA contains 1.5 cc of product, and it will be diluted 1:1 with 1.0 cc of normal saline solution and 0.5 cc of 1% Lidocaine with a ratio of 1:100,000 epinephrine in the target sites.

Trial Locations (1)

91105

K. Kay Durairaj, MD, FACS, A Medical Corporation, Pasadena

All Listed Sponsors
collaborator

Merz North America, Inc.

INDUSTRY

lead

Kalpna Kay Durairaj, MD, FACS

OTHER